FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and pharmaceutical industry, and concerns a composition having a complex effect on the vascular endothelium. The composition contains L-arginine or L-citrulline, and an arginase inhibitor in a solid dosage form. The composition possess an endothelial protective, vasodilating and angioprotective effect. The synergetic effect is provided by combining NO donators and the arginase inhibitors in the retard form.
EFFECT: preparing the composition possessing the complex effect on the vascular endothelium.
7 cl, 5 ex, 54 tbl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CORRECTION OF PLACENTAL MICROCIRCULATION DISORDER BY ARGINASE II INHIBITOR | 2016 |
|
RU2644271C1 |
| METHOD OF CORRECTION OF EXPERIMENTAL GESTATIONAL TOXICOSIS BY TAURINE ADMINISTRATION | 2017 |
|
RU2672475C2 |
| METHOD OF CORRECTION OF EXPERIMENTAL GESTOSIS BY ADEMETIONINE ADMINISTRATION | 2017 |
|
RU2655100C1 |
| METHOD FOR ENDOTHELIOPROTECTION IN ADMA-SIMILAR GESTOSIS MODEL BY ARGINASE II INHIBITOR | 2016 |
|
RU2639415C1 |
| METHOD OF CORRECTING ENDOTHELIAL DYSFUNCTION BY L-NORVALIN IN CASE OF ADMA-LIKE MODEL OF GESTOSIS | 2010 |
|
RU2449381C1 |
| METHOD OF ENDOTHELIAL DYSFUNCTION CORRECTION BY COMBINATION OF TRIMETAZIDINE AND L-ARGININE IN L-NAME-INDUCED NITROGEN OXIDE DEFICIENCY | 2009 |
|
RU2421822C2 |
| METHOD FOR ENDOTHELIAL PROTECTION WITH API-PHYTOCOMPOSITION | 2013 |
|
RU2524799C1 |
| METHOD FOR SIMULATION OF ENDOTHELIAL DYSFUNCTION ASSOCIATED WITH LOW GRADATION SYSTEMIC INFLAMMATION AND OXIDATIVE STRESS | 2016 |
|
RU2618657C1 |
| METHOD FOR PREVENTING THE DEVELOPMENT OF COMPLICATIONS AT EXPERIMENTAL MYOCARDIAL INFARCTION IN RATS | 2004 |
|
RU2268718C1 |
| METHOD OF CLOPIDOGREL-BASED CORRECTION OF ENDOTHELIAL DYSFUNCTION IN L-NAME INDUCED NITRIC OXIDE DEFICIENCY | 2008 |
|
RU2364394C1 |
